A novel conserved cochlear gene, OTOR: Identification, expression analysis, and chromosomal mapping

Genomics

Volumn 66, Issue 3, 2000, Pages 242-248

  Robertson, Nahid G ^a   Heller, Stefan ^c   Lin, Jason S ^a   Resendes, Barbara L ^a,b   Weremowicz, Stanislawa ^a,b   Denis, Charlotte S ^c   Bell, Andrea M ^c   Hudspeth, A J ^c   Morton, Cynthia C ^a,b  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c ROCKEFELLER UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

OTORAPLIN; RETINOIC ACID; SIGNAL PEPTIDE; UNCLASSIFIED DRUG;

AMINO ACID SEQUENCE; ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CHICKEN; CHROMOSOME 20; CHROMOSOME MAP; COCHLEA; DNA LIBRARY; GENE EXPRESSION; GENE LOCATION; GENETIC ANALYSIS; HEARING LOSS; HUMAN; HUMAN CELL; HUMAN TISSUE; MAMMAL; MELANOMA CELL; NONHUMAN; NORTHERN BLOTTING; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; SEQUENCE ANALYSIS;

ANIMALIA; EUKARYOTA; GALLUS GALLUS; MAMMALIA; RANA CATESBEIANA;

EID: 0034659447     PISSN: 08887543     EISSN: None     Source Type: Journal    
DOI: 10.1006/geno.2000.6224     Document Type: Article

References (40)

1. Altschul S. F., Madden T. L., Schaffer A. A., Zhang J., Zhang Z., Miller W., Lipman D. J. Gapped BLAST and PSI-BLAST: A new generation of protein database search programs. Nucleic Acids Res. 25:1997;3389-3402.
2. Anad F., Burn J., Matthews D., Cross I., Davison B. C., Mueller R., Sands M., Lillington D. M., Eastham E. Alagille syndrome and deletion of 20p. J. Med. Genet. 27:1990;729-737.
3. Blesch A., Bosserhoff A. K., Apfel R., Behl C., Hessdoerfer B., Schmitt A., Jachimczak P., Lottspeich F., Buettner R., Bogdahn U. Cloning of a novel malignant melanoma-derived growth-regulatory protein, MIA. Cancer Res. 54:1994;5695-5701.
4. Chirgwin J. R., Przybyla A. E., MacDonald R. J., Rutter W. J. Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease. Biochemistry. 18:1979;5294-5299.
5. Cohen-Salmon M., El-Amraoui A., Leibovici M., Petit C. Otogelin: A glycoprotein specific to the acellular membranes of the inner ear. Proc. Natl. Acad. Sci. USA. 94:1997;14450-14455.
6. Crozet F., el Amraoui A., Blanchard S., Lenoir M., Ripoll C., Vago P., Hamel C., Fizames C., Levi-Acobas F., Depetris D., Mattei M. G., Weil D., Pujol R., Petit C. Cloning of the genes encoding two murine and human cochlear unconventional type I myosins. Genomics. 40:1997;332-341.
7. de Kok Y. J. M., Bom S. J. H., Brunt T. M., Kemperman M. H., van Beusekom E., van der Velde-Visser S. D., Robertson N. G., Morton C. C., Huygen P. L. M., Verhagen W. I. M., Brunner H. G., Cremers C. W. R. J., Cremers F. P. M. A Pro51Ser mutation in the COCH gene is associated with late onset autosomal dominant progressive sensorineural hearing loss with vestibular defects. Hum. Mol. Genet. 8:1999;361-366.
8. Devereux J., Haeberli P., Smithies O. A comprehensive set of sequence analysis programs for the VAX. Nucleic Acids Res. 12:1984;387-395.
9. Dietz U. H., Sandell L. J. Cloning of a retinoic acid-sensitive mRNA expressed in cartilage and during chondrogenesis. J. Biol. Chem. 271:1996;3311-3316.
10. Feinberg A. P., Vogelstein B. A technique for radiolabeling DNA restriction endonuclease fragments to high specific activity. Anal. Biochem. 137:1984;266-267.
11. Fransen E., Verstreken M., Verhagen W. I., Wuyts F. L., Huygen P. L., D'Haese P., Robertson N. G., Morton C. C., McGuirt W. T., Smith R. J., Declau F., Heyning P. H., Camp G. V. High prevalence of symptoms of Meniere's disease in three families with a mutation in the COCH gene. Hum. Mol. Genet. 8:1999;1425-1429.
12. Gorlin R. J., Toriello H. V., Cohen M. M. Hereditary Hearing Loss and Its Syndromes. 1995;Oxford Univ. Press, New York.
13. Heath J. K., Rodan S. B., Yoon K., Rodan G. A. Rat calvarial cell lines immortalized with SV-40 large T antigen: Constitutive and retinoic acid-inducible expression of osteoblastic features. Endocrinology. 124:1989;3060-3068.
14. Heller S., Sheane C. A., Javed Z., Hudspeth A. J. Molecular markers for cell types of the inner ear and candidate genes for hearing disorders. Proc. Natl. Acad. Sci. USA. 95:1998;11400-11405.
15. Iwamoto M., Golden E. B., Adams S. L., Noji S., Pacifici M. Responsiveness to retinoic acid changes during chondrocyte maturation. Exp. Cell Res. 205:1993;213-224.
16. Khetarpal U., Robertson N. G., Yoo T. J., Morton C. C. Expression and localization of COL2A1 mRNA and type II collagen in human fetal cochlea. Hear. Res. 79:1994;59-73.
17. Krantz I. D., Piccoli D. A., Spinner N. B. Clinical and molecular genetics of Alagille syndrome. Curr. Opin. Pediatr. 11:1999;558-564.
18. Kyte J., Doolittle R. F. A simple method for displaying the hydropathic character of a protein. J. Mol. Biol. 157:1982;105-132.
19. Lau W. F., Tertinegg I., Heersche J. N. Effects of retinoic acid on cartilage differentiation in a chondrogenic cell line. Teratology. 47:1993;555-563.
20. Li L., Krantz I. D., Deng Y., Genin A., Banta A. B., Collins C. C., Qi M., Trask B. J., Kuo W. L., Cochran J., Costa T., Pierpont M. E., Rand E. B., Piccoli D. A., Hood L., Spinner N. B. Alagille syndrome is caused by mutations in human Jagged1, which encodes a ligand for Notch1. Nat. Genet. 16:1997;243-251.
21. Marazita M. L., Ploughman L. M., Rawlings B., Remington E., Arnos K. S., Nance W. E. Genetic epidemiological studies of early-onset deafness in the U.S. school-age population. Am. J. Med. Genet. 46:1993;486-491.
22. McKenna M. J., Kristiansen A. G., Bartley M. L., Rogus J. J., Haines J. L. Association of COL1A1 and otosclerosis: Evidence for a shared genetic etiology with mild osteogenesis imperfecta. Am. J. Otol. 19:1998;604-610.
23. Morton N. E. Genetic epidemiology of hearing impairment. Ann. N.Y. Acad. Sci. 630:1991;16-31.
24. Neame P. J., Tapp H., Azizan A. Noncollagenous, nonproteoglycan macromolecules of cartilage. Cell. Mol. Life Sci. 55:1999;1327-1340.
25. Ney P. A., Andrews N. C., Jane S. M., Safer B., Purucker N. E., Weremowicz S., Morton C. C., Goff S. C., Orkin S. H., Niehuis A. W. Purification of the human NF-E2 complex: cDNA cloning of the hematopoietic cell-specific subunit and evidence for an associated partner. Mol. Cell. Biol. 13:1993;5604-5612.
26. Oda T., Elkahloun A. G., Pike B. L., Okajima K., Krantz I. D., Genin A., Piccoli D. A., Meltzer P. S., Spinner N. B., Collins F. S., Chandrasekharappa S. C. Mutations in the human Jagged1 gene are responsible for Alagille syndrome. Nat. Genet. 16:1997;235-242.
27. Reardon W. Genetic deafness. J. Med. Genet. 29:1992;521-526.
28. Robertson N. G., Khetarpal U., Gutiérrez-Espeleta G. A., Bieber F. R., Morton C. C. Isolation of novel and known genes from a human fetal cochlear cDNA library using subtractive hybridization and differential screening. Genomics. 23:1994;42-50.
29. Robertson N. G., Lu L., Heller S., Merchant S. N., Eavey R. D., McKenna M., Nadol J. B. Jr., Miyamoto R. T., Linthicum F. H. Jr., Lubianca Neto J. F., Hudspeth A. J., Seidman C. E., Morton C. C., Seidman J. G. Mutations in a novel cochlear gene cause DFNA9, a human nonsyndromic deafness with vestibular dysfunction. Nat. Genet. 20:1998;299-303.
30. Robertson N. G., Morton C. C. Beginning of a molecular era in hearing and deafness. Clin. Genet. 55:1999;149-159.
31. Robertson N. G., Skvorak A. B., Yin Y., Weremowicz S., Johnson K. R., Kovatch K. A., Battey J. F., Bieber F. R., Morton C. C. Mapping and characterization of a novel cochlear gene in human and in mouse: A positional candidate gene for a deafness disorder, DFNA9. Genomics. 46:1997;345-354.
32. Sandell L. J., Dietz U. H., Nalin A. M. mRNA encoding a novel growth regulatory factor is coexpressed with type II procollagen during chondrogenesis. Ann. N. Y. Acad. Sci. 785:1996;325-327.
33. Schaeren-Wiemers N., Gerfin-Moser A. A single protocol to detect transcripts of various types and expression levels in neural tissue and cultured cells: In situ hybridization using digoxigenin-labeled cRNA probes. Histochemistry. 100:1993;431-440.
34. Skvorak A. B., Weng Z., Yee A. J., Robertson N. G., Morton C. C. Human cochlear expressed sequence tags provide insight into cochlear gene expression and identify candidate genes for deafness. Hum. Mol. Genet. 8:1999;439-452.
35. Thomas P. S. Hybridization of denatured RNA and small DNA fragments transferred to nitrocellulose. Proc. Natl. Acad. Sci. USA. 77:1980;5201-5205.
36. Tickle C., Alberts B., Wolpert L., Lee J. Local application of retinoic acid to the limb bond mimics the action of the polarizing region. Nature. 296:1982;564-566.
37. Tomek M. S., Brown M. R., Mani S. R., Ramesh A., Srisailapathy C. R., Coucke P., Zbar R. I., Bell A. M., McGuirt W. T., Fukushima K., Willems P. J., Van Camp G., Smith R. J. Localization of a gene for otosclerosis to chromosome 15q25-q26. Hum. Mol. Genet. 7:1998;285-290.
38. Van Camp, G, and, Smith, R. J. H. 2000, Hereditary hearing loss homepage. WWW URL, http://dnalab-www.uia.ac.be/dnalab/hhh .
39. von Heijne G. A new method for predicting signal sequence cleavage sites. Nucleic Acids Res. 14:1986;4683-4690.
40. Wang P. C., Merchant S. N., McKenna M. J., Glynn R. J., Nadol J. B. Jr. Does otosclerosis occur only in the temporal bone? Am. J. Otol. 20:1999;162-165.